BT
PFE icon

Banque Transatlantique’s Pfizer PFE Stock Holding History

Banque Transatlantique’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$657K Buy
27,165
+1,450
+6% +$37.9K 0.01% 202
2026
Q1 		$727K Buy
25,715
+2,650
+11% +$70.6K 0.02% 160
2025
Q4 		$575K Sell
23,065
-4,600
-17% -$116K 0.01% 90
2025
Q3 		$704K Sell
27,665
-3,500
-11% -$86.4K 0.02% 88
2025
Q2 		$763K Sell
31,165
-32,691
-51% -$762K 0.02% 81
2025
Q1 		$1.61M Sell
63,856
-3,150
-5% -$82.4K 0.05% 71
2024
Q4 		$1.77M Buy
+67,006
New +$1.82M 0.05% 67

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Banque Transatlantique's PFE Position: Q2 2026 in Review

Banque Transatlantique increased its Pfizer (PFE) stake by 5.6% in Q2 2026, buying an estimated $37.9K and bringing the position to 27,165 shares worth $657K. The position accounts for 0.01% of the portfolio, ranked #202.

Banque Transatlantique first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.77M in Q4 2024. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Banque Transatlantique held 27,165 shares of Pfizer worth $657K as of Q2 2026.
  • Banque Transatlantique bought 1,450 Pfizer shares in Q2 2026, an estimated $37.9K.
  • Pfizer made up 0.01% of Banque Transatlantique's portfolio in Q2 2026, its #202 holding.
  • Banque Transatlantique first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Pfizer position peaked at $1.77M in Q4 2024.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.